fludarabine and Pemphigus

fludarabine has been researched along with Pemphigus in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (22.22)18.2507
2000's6 (66.67)29.6817
2010's0 (0.00)24.3611
2020's1 (11.11)2.80

Authors

AuthorsStudies
Cao, L; Du, XY; Fan, L; Li, JY; Wang, F; Wang, L; Xu, W; Zhu, HY1
Albert, S; Bhogal, B; Black, MM; Oyama, N; Powell, AM; Sakuma-Oyama, Y1
Creamer, D; Devereux, S; Mufti, G; Perera, GK; Salisbury, J1
Anhalt, GJ; Cummins, DL; Meyerle, JH; Mimouni, D; Owens, N; Tzu, J1
Hashimoto, T; Hull, CM; Ishii, N; Leiferman, KM; Taintor, AR; Zone, JJ1
Antonov, M; Buyukunal, E; Demirkesen, C; Kursunoglu, SG; Ozguroglu, M; Serdaroglu, S; Turna, H; Yanmaz, MT; Yildiz, O1
Bachelez, H; Bazarbachi, A; Dehen, L; Delmer, A; Dubertret, L; Zittoun, R1
Blaschke, V; Braess, J; Brinck, U; Dames, K; Letschert, M; Neumann, C; Reich, K; Rünger, TM; Wörmann, B1
Allen, J; Amagai, M; Carmichael, AJ; Dean, D; Frith, P; Gooptu, C; Hashimoto, T; Littlewood, TJ; Lyon, CC; MacWhannell, A; Oliwiecki, S; Wojnarowska, F1

Reviews

1 review(s) available for fludarabine and Pemphigus

ArticleYear
Paraneoplastic pemphigus secondary to fludarabine evolving into unusual oral pemphigus vegetans.
    Journal of the European Academy of Dermatology and Venereology : JEADV, 2004, Volume: 18, Issue:3

    Topics: Aged; Biopsy, Needle; Fluorescent Antibody Technique, Indirect; Follow-Up Studies; Humans; Immunohistochemistry; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Mycophenolic Acid; Paraneoplastic Syndromes; Pemphigus; Risk Assessment; Severity of Illness Index; Stomatitis; Treatment Outcome; Vidarabine

2004

Other Studies

8 other study(ies) available for fludarabine and Pemphigus

ArticleYear
Chronic lymphocytic leukemia-associated paraneoplastic pemphigus: potential cause and therapeutic strategies.
    Scientific reports, 2020, 10-01, Volume: 10, Issue:1

    Topics: Adult; Aged, 80 and over; Antineoplastic Agents; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Paraneoplastic Syndromes; Pemphigus; Prednisone; Prognosis; Retrospective Studies; Rituximab; Vidarabine

2020
PNP with Waldenström's macroglobulinaemia.
    Clinical and experimental dermatology, 2005, Volume: 30, Issue:1

    Topics: Aged; Anti-Inflammatory Agents; Antineoplastic Agents; Drug Eruptions; Fatal Outcome; Humans; Male; Paraneoplastic Syndromes; Pemphigus; Skin Neoplasms; Vidarabine; Waldenstrom Macroglobulinemia

2005
Lichenoid paraneoplastic pemphigus in the absence of detectable antibodies.
    Journal of the American Academy of Dermatology, 2007, Volume: 56, Issue:1

    Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antibody Formation; Antineoplastic Combined Chemotherapy Protocols; Autoantibodies; B-Lymphocytes; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Esophageal Diseases; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunity, Cellular; Interleukin-2; Leukemia, Lymphocytic, Chronic, B-Cell; Lichenoid Eruptions; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mucositis; Paraneoplastic Syndromes; Pemphigus; Prednisone; Recurrence; Rituximab; T-Lymphocytes; Vidarabine; Vincristine

2007
A novel case of IgA paraneoplastic pemphigus associated with chronic lymphocytic leukemia.
    Journal of the American Academy of Dermatology, 2007, Volume: 56, Issue:5 Suppl

    Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Fluorescent Antibody Technique, Direct; Humans; Immunoglobulin A; Immunologic Factors; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Paraneoplastic Syndromes; Pemphigus; Rituximab; Vidarabine

2007
Paraneoplastic pemphigus associated with fludarabine use.
    Medical oncology (Northwood, London, England), 2007, Volume: 24, Issue:1

    Topics: Antineoplastic Agents; Humans; Immunoglobulin G; Keratinocytes; Lymphoma, Non-Hodgkin; Male; Middle Aged; Paraneoplastic Syndromes; Pemphigus; Vidarabine

2007
Lethal paraneoplastic pemphigus following treatment of chronic lymphocytic leukaemia with fludarabine.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1995, Volume: 6, Issue:7

    Topics: Antineoplastic Agents; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Middle Aged; Paraneoplastic Syndromes; Pemphigus; Vidarabine

1995
Graft-versus-host disease-like immunophenotype and apoptotic keratinocyte death in paraneoplastic pemphigus.
    The British journal of dermatology, 1999, Volume: 141, Issue:4

    Topics: Adult; CD8-Positive T-Lymphocytes; Drug Eruptions; Epidermis; Female; Histocompatibility Antigens Class II; Humans; Immunohistochemistry; Immunophenotyping; Immunosuppressive Agents; In Situ Nick-End Labeling; Intercellular Adhesion Molecule-1; Lymphoma, Non-Hodgkin; Pemphigus; Reverse Transcriptase Polymerase Chain Reaction; Vidarabine

1999
Paraneoplastic pemphigus: an association with fludarabine?
    The British journal of dermatology, 2001, Volume: 144, Issue:6

    Topics: Antineoplastic Agents; Drug Eruptions; Fatal Outcome; Fluorescent Antibody Technique; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Paraneoplastic Syndromes; Pemphigus; Vidarabine

2001